LNTH
Lantheus Holdings, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$99.92
+0.12%Forward multiples
Based on analyst estimates
- P/E forward
- 16.76x
- P/E 2026E
- 18.47x
- P/E 2027E
- 15.61x
- P/E 2028E
- 12.71x
- P/S forward
- 4.10x
Trailing multiples
Trailing twelve months
- P/E TTM
- 23.73x
- PEG TTM
- 0.57x
- Price / book
- 4.97x
- Price / sales
- 4.19x
- Price / cash flow
- 15.81x
Enterprise value
- Enterprise value
- $6.6B
- EV / sales
- 4.21x
- EV / EBITDA
- 13.91x
- EV / EBIT
- 21.69x
- Market cap
- $6.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026